Navigation Links
MEDRAD, INC. Announces European Approval and Launch of the Cotavance™ Drug Eluting Balloon With Paccocath® Technology
Date:5/16/2011

is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.

Forward-looking statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

(1) Cotavance is not approved or available for sale in the United States.

(2) Tepe G et al. 2008. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 14; 358 (7):689-99.

(3) Unverdorben M. et al. 2009. Paclitaxel-Coated Balloon Catheter versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis. Circulation. 2009;119:2986-2994.

(4) Scheller B. et al. 2008. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol. 97(10):773-81.

(5) Werk, M. et al. 2008. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 23;118(13):1358-65.

(6) Duda SH, Bosiers M, Lamme J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Th
'/>"/>

SOURCE MEDRAD, INC.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Telik Announces First Quarter 2011 Financial Results
2. Unilife Announces Financial Results for the Third Quarter of Fiscal 2011
3. Global Pharm Holdings Group Announces First Quarter 2011 Financial Results
4. Breckenridge Pharmaceutical Announces Settlement of Actos® (Pioglitazone Hydrochloride) Patent Litigation
5. Perrigo Announces FDA Final Approval for Ranitidine 150 - Generic Equivalent to Zantac 150®
6. UBM Canon Medical Device Content Team Announces Upcoming Virtual Event Content Topics
7. New Mexico Software Announces 2011 First Quarter Financial Results
8. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
9. Neurologix Announces First Quarter 2011 Financial Results
10. Naviscan Announces Partnership With Chindex Medical Limited for Mainland China, Hong Kong and Macau
11. China New Borun Announces First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)...  Sprout Pharmaceuticals today announced positive preliminary results from a ... flibanserin up to 200 mg at bedtime had no next-day ... 20 th Annual Fall Scientific Meeting of the Sexual ... Miami . The Phase 1 ... Letter and the Formal Dispute Resolution that was filed in ...
(Date:11/22/2014)... -- New data demonstrates that flibanserin, a novel, non-hormonal medicine ... sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD), does not ... women when taken at bedtime. The data was presented ... America,s (SMSNA) 20th Annual Fall Scientific Meeting ... SMSNA accepted this study as a late breaking abstract ...
(Date:11/22/2014)... JUNCTION, N.J. , Nov. 21, 2014 /PRNewswire/ ... company commercializing its European Union approved CytoSorb® cytokine ... worldwide, was awarded the Beacon of Light Award ... Awards Celebration.  Dr. Phillip ... "It is an honor to be recognized by ...
Breaking Medicine Technology:Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4
... identify patients at a high risk for ... events in heart failure patients, TORONTO, Sept. 24 ... Access and Review Trending Information and Evaluate,Correlation to Symptoms ... Annual Scientific Meeting of the Heart Failure Society of ...
... Arpida,Ltd. (SWX: ARPN) today announced the completion of ... oral iclaprim in patients with,complicated Skin and Skin ... as a multi-centre, double-blind comparative,study. Patients suffering from ... days of treatment and were then randomised to ...
Cached Medicine Technology:Can Implantable Devices for Heart Failure Help Assess Risk of Future Adverse Events for Heart Failure Patients? 2Can Implantable Devices for Heart Failure Help Assess Risk of Future Adverse Events for Heart Failure Patients? 3Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 2Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 3
(Date:11/23/2014)... 2014 Locks-Magnetic.com, a notable magnetic locks ... all the new products are available at low rates ... is proud of the new emergency doors. The emergency ... customers can choose from several colors. All of the ... emergency door release is not as easy as many ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 23, 2014 ... the market such as its significance, programs and ... globally and Chinese suppliers major market gamers in ... company information, item specifications, prospective, manufacturing value, and ... statistical research, the evaluation symbolizes the globally and ...
(Date:11/23/2014)... 23, 2014 To show thanks to new ... collection of white evening dresses for weddings. Customers ... 24/7. , iFitDress.com is a distinguished dress manufacturer, and it ... by worldwide customers for a very long time. The CEO ... a customer will be able to buy not only a ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power suppliers are popular ... its new collection of power suppliers. Additionally, it has ... suppliers. All the new models come with big discounts, ... Dec. 20, 2014. , SWAccessControl.com has thousands of happy ... for a long time. It is very wise to ...
(Date:11/23/2014)... New York, NY (PRWEB) November 23, 2014 ... over the past month in a federal litigation involving ... over similar diabetes medications, Bernstein Liebhard LLP reports. ... that 566 claims over a class of Type 2 ... been filed in the U.S. District Court, Southern District ...
Breaking Medicine News(10 mins):Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
... donated over $7 Million for the Jimmy Fund, ... store owners,in New England Monday raised just over ... proceeds generated from the 11th Annual,Dunkin, Donuts George ... by Dunkin, Donuts Northeast Distribution Center (NEDCP),and held ...
... Indulge yourself on a,lazy Sunday with a great meal and ... to unwind., Every Sunday, from 12pm - 4pm, Voda Spa ... Spa,ing and brunching:, Brunch Massage $140 ... $175, Choose from a selection of delicious dishes ...
... is still working in more than 30,earthquake-affected communities ... When the massive,earthquake struck this region last August ... 140,000 people homeless.,Although the spotlight has moved on, ... working with the Peruvian Red Cross to help ...
... scientists have made a breakthrough in understanding how a ... help the body to fight bacterial infections in the ... in Nature Medicine. , Hans-Uwe Simon, ... from the University of Utah School of Medicine, and ...
... Best Medical Spa in America. Raleigh, NC medspa Blue Water Spa owner ... Medspa conference on October 6, 2008 in Orlando, FL. , ... Raleigh, ... has been voted Best Medical Spa in America. Medical Spa Owner Kile ...
... 14-year old founder of The Blue Lion Foundation is raffling her tickets ... and inspire people of all ages to overcome challenges through persistence and ... ... Allen,s father purchased tickets for her to The Jonas Brothers, she decided ...
Cached Medicine News:Health News:Dunkin' Donuts Event Raises $800,000 for Cancer Research in One Day 2Health News:One Year Later: Red Cross Helping Peru Earthquake Survivors Rebuild 2Health News:White blood cell uses DNA 'catapult' to fight infection 2Health News:Medical Spa Consulting from Best Medspa in America to Provide Advanced Medical Spa Education at Medspa Conference in Orlando, FL 2Health News:Medical Spa Consulting from Best Medspa in America to Provide Advanced Medical Spa Education at Medspa Conference in Orlando, FL 3Health News:Pittsburgh Teen Raffles Her Jonas Brothers Tickets to Educate and Inspire 2Health News:Pittsburgh Teen Raffles Her Jonas Brothers Tickets to Educate and Inspire 3
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
FlexStationII offers the highest level of flexibility in developing functional cellular assays and analyzing real time kinetic data....
... The C&L Dye Fluorometer utilizes unique ... the illumination and detection optics. The filter ... emission for numerous types of applications. With ... settle on measuring one or two wavelengths. ...
... The Modulus™ is a ... designed to give you ... fluorescence, luminescence, and absorbance. ... dedicated fluorometer, dedicated luminometer, ...
Medicine Products: